Published in JAMA Ophthalmol on January 01, 2013
[Choroidal tumor with accompanying papilledema]. Ophthalmologe (2014) 0.75
Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol (2006) 1.33
Cystoid macular edema with equatorial choroidal melanoma. Arch Ophthalmol (1978) 1.23
Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol (1995) 1.13
Mechanisms of optic disc swelling with diffuse choroidal melanomas: clinicopathologic correlations. Br J Ophthalmol (1982) 1.09
Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma. Eur J Ophthalmol (2011) 0.99
Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma. Can J Ophthalmol (2009) 0.99
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet (2011) 2.61
Charles Bonnet syndrome and Terson's syndrome from subarachnoid hemorrhage: good news from bad news. Graefes Arch Clin Exp Ophthalmol (2012) 1.98
Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci (2007) 1.76
Susac syndrome: an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol (2011) 1.50
Cerebrospinal fluid outflow: an evolving perspective. Brain Res Bull (2008) 1.25
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosomes Cancer (2013) 1.18
Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest Ophthalmol Vis Sci (2008) 1.12
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. J Clin Oncol (2005) 1.08
Vision loss after spine surgery: review of the literature and recommendations. Neurosurg Focus (2007) 1.03
Hemangioblastoma of the cerebellopontine angle. Arch Otolaryngol Head Neck Surg (2010) 1.02
Retinal and optic nerve head pathology in Susac's syndrome. Ophthalmology (2011) 1.02
Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma. Mod Pathol (2011) 1.00
Postmortem magnetic resonance imaging to guide the pathologic cut: individualized, 3-dimensionally printed cutting boxes for fixed brains. J Neuropathol Exp Neurol (2014) 0.99
Extradural dermoid tumor of the petrous apex. Case report. J Neurosurg (2007) 0.96
Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition. Melanoma Res (2011) 0.96
Increased hypoxia following vessel targeting in a murine model of retinoblastoma. Invest Ophthalmol Vis Sci (2009) 0.95
West Nile virus-associated optic neuritis and chorioretinitis. Am J Ophthalmol (2003) 0.95
Endophthalmitis after open globe injuries. Am J Ophthalmol (2009) 0.94
Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease. J Neurochem (2010) 0.93
In vitro model of cerebrospinal fluid outflow through human arachnoid granulations. Invest Ophthalmol Vis Sci (2006) 0.93
Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits. J Neuropathol Exp Neurol (2006) 0.92
MET oncogene inhibition as a potential target of therapy for uveal melanomas. Invest Ophthalmol Vis Sci (2010) 0.91
Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients. Ophthalmic Genet (2015) 0.90
Expression of vascular endothelial growth factor in uveal melanoma is independent of 6p21-region copy number. Clin Cancer Res (2005) 0.89
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Exp Eye Res (2012) 0.89
Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate. Invest Ophthalmol Vis Sci (2010) 0.89
Endoscopic transconjunctival surgical approach to the optic nerve and medial intraconal space: a cadaver study. Neurosurgery (2008) 0.88
Delivery of antiangiogenic and antioxidant drugs of ophthalmic interest through a nanoporous inorganic filter. Mol Vis (2004) 0.88
High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide. Invest Radiol (2009) 0.86
Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature. Ophthalmic Res (2009) 0.85
Ex vivo model of cerebrospinal fluid outflow across human arachnoid granulations. Invest Ophthalmol Vis Sci (2008) 0.84
A chick model of retinal detachment: cone rich and novel. PLoS One (2012) 0.83
Visual loss with West Nile virus infection: a wider spectrum of a "new" disease. Clin Infect Dis (2004) 0.83
Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma. Retina (2010) 0.83
Intravitreal devices for the treatment of vitreous inflammation. Mediators Inflamm (2012) 0.83
Method for novel anti-cancer drug development using tumor explants of surgical specimens. J Vis Exp (2011) 0.83
Characterization of cytoskeletal and junctional proteins expressed by cells cultured from human arachnoid granulation tissue. Cerebrospinal Fluid Res (2005) 0.83
Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model. Pediatr Rheumatol Online J (2008) 0.81
Long-term survivors with metastatic uveal melanoma. Open Ophthalmol J (2012) 0.81
Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection. Liver Int (2009) 0.81
Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype. Invest Ophthalmol Vis Sci (2010) 0.81
Custom-made "Nag" eye plaques for 125I brachytherapy. Int J Radiat Oncol Biol Phys (2003) 0.81
Management of fluocinolone implant dissociation during implant exchange. Arch Ophthalmol (2009) 0.80
Metastasis development at the site of cervical spine arthrodesis. Acta Neurochir (Wien) (2009) 0.79
In vitro anti-uveal melanoma activity of phenolic compounds from the Egyptian medicinal plant Acacia nilotica. Fitoterapia (2011) 0.79
Spinal myxopapillary ependymoma metastatic to bilateral internal auditory canals. Ann Otol Rhinol Laryngol (2008) 0.79
Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment. Invest Ophthalmol Vis Sci (2014) 0.78
Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist. Int J Dermatol (2014) 0.78
Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition. Fam Cancer (2011) 0.78
Solitary pituitary sarcoidosis with normal endocrine function: case report. J Neurosurg (2008) 0.77
Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency. J Neurol (2015) 0.76
The wayward implant: orbital silicone plate extrusion associated with squamous epithelial downgrowth and infection. Orbit (2002) 0.76
Toward failure analyses in systems biology. Wiley Interdiscip Rev Syst Biol Med (2010) 0.76
Rapid formation and resolution of cataracts following orthopedic surgery for a patient with Charcot-Marie-Tooth disease. Arch Ophthalmol (2012) 0.76
Patterns of retinal hemorrhage associated with increased intracranial pressure in children. Pediatrics (2013) 0.76
Histopathology of optic nerve pit-associated maculopathy. Clin Ophthalmol (2012) 0.75
Denilieukin diftitox vision loss is not posterior ischemic optic neuropathy. Leuk Lymphoma (2008) 0.75
Fluorescein and indocyanine green angiographies in Susac syndrome. Retina (2008) 0.75
Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination. Clin Ophthalmol (2013) 0.75
Type II (adult onset) Alexander disease in a paraplegic male with a rare D128N mutation in the GFAP gene. Clin Neuropathol (2015) 0.75
Brain tumor imaging and cancer management: the neuro-oncologists perspective. Top Magn Reson Imaging (2006) 0.75
Atypical cat scratch disease with vitritis, serous macular detachment, neuroretinitis, and retrobulbar optic neuritis. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
Surgical Management of Carney Complex-Associated Pituitary Pathology. Neurosurgery (2016) 0.75
Systemic treatment of vitreous inflammation. Mediators Inflamm (2012) 0.75
Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. Exp Eye Res (2011) 0.75
Re: Susac syndrome in four male patients. Retina (2007) 0.75
Expression of somatostatin receptors 1 and 2 in human choroid plexus and arachnoid granulations: implications for idiopathic intracranial hypertension. Arch Ophthalmol (2002) 0.75
Measurement of Perceived Stress in Age-Related Macular Degeneration. Optom Vis Sci (2017) 0.75
Charles Bonnet syndrome and Terson's syndrome: good news from bad news. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Pediatric nasopharyngeal carcinoma with retinal metastasis. Retin Cases Brief Rep (2009) 0.75
Required reduction in dose of chemotherapy for retinoblastoma due to down syndrome-associated chemosensitivity. Retin Cases Brief Rep (2010) 0.75
Diagnostic and therapeutic challenges. Retina (2013) 0.75
Photodynamic therapy and vitrectomy for a large optic nerve hemangioma with neovascularization and retinal detachment: a clinicopathologic correlation. Retin Cases Brief Rep (2009) 0.75
Calcification of combined hamartoma of the retina and retinal pigment epithelium over 15 years. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
Endoscopic orbital roof fenestration as an alternative treatment option for idiopathic intracranial hypertension: a cadaveric anatomical study. J Neuroophthalmol (2011) 0.75